# CellAge Ltd: Form D filing

CellAge Ltd, a biotechnology company in Glasgow, United Kingdom, filed a Form D with the SEC in 2017. The latest, on April 13, 2017, reports $25,065 sold of a $25,065 offering to 3 investors.

Find out what CellAge Ltd does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20CellAge%20Ltd%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=CellAge%20Ltd&page=%2Fdata%2Fform-d%2Fcompany%2Fcellage-ltd-1703768)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20CellAge%20Ltd%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=CellAge%20Ltd&page=%2Fdata%2Fform-d%2Fcompany%2Fcellage-ltd-1703768)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology
- [Form D filings](https://specstream.ai/data/form-d): 44,302 rows, by operating companies, filed since November 1, 2024, $523.02, or the new rows each week for $92.05 a month. Buy: https://specstream.ai/data/form-d

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 272, BATH STREET, Glasgow, United Kingdom, G2 4J
- Phone: 07907696864
- Industry: Biotechnology
- Entity type: Limited Liability Company
- Incorporated in: United Kingdom
- Year incorporated: 2016
- Revenue range: $1 - $1,000,000
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1703768

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Apr 13, 2017 | New notice | $25,065 | $25,065 | $0 | 3 | Mar 31, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1703768/000170376817000002/0001703768-17-000002-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Mantas Matjusaitis | Executive Officer, Director |  |

[Every Form D from the week of Apr 10, 2017](https://specstream.ai/data/form-d/week/2017-04-10) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what CellAge Ltd reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).